Eric Lander Active in First Few Weeks as OSTP Director; Community Awaits PCAST Appointments
In the first few weeks since his confirmation on May 28, Director of the White House Office of Science and Technology Policy (OSTP) Eric Lander has been active in advocating for President Biden’s ambitious science policy agenda, most notably the proposal for the Advanced Research Projects Agency for Health (ARPA-H), the DARPA-like research agency proposed to be housed within the National Institutes of Health (NIH). During the June 10-11 meeting of the Advisory Committee to the Director of NIH, Lander presented a more thorough vision of ARPA-H’s role as a high risk, high reward vehicle to address specific societal questions. A recording of the presentation is available on the NIH website.
With Lander’s confirmation behind the Administration, the scientific community now awaits announcement of appointments to the President’s Council of Advisors on Science and Technology (PCAST). PCAST, which Lander will co-chair, is the nation’s highest-level advisory body related to science policy issues, advising the President and his Administration on all aspects of the STEM enterprise and ways to apply it to Administration priorities. The last Administration did not reconstitute and appointment members to PCAST until almost three years into its term. With President Biden’s laser focus on science and technology, it is expected that PCAST will be populated sometime this year. We will continue to report on new developments.